Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 18375411.
- Also identified by DOI 10.2337/dc08-0194 and PMC identifier 2453666.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess whether sex differences exist in the effective control and medication treatment intensity of cardiovascular disease (CVD) risk factors. We performed a cross-sectional analysis including 44,893 patients with type 2 diabetes (51% women). End points included uncontrolled CVD risk factors (LDL cholesterol > or =130 mg/dl, systolic blood pressure [SBP] > or =140 mmHg, and A1C > or =8%) and the intensity of medical management in patients with uncontrolled CVD risk factors. Multiple-adjusted odds ratios were calculated after stratification for the presence of CVD (present in 39% of the patients). Women with CVD were less likely to have SBP, LDL cholesterol, and A1C controlled and less likely to receive intensive lipid-lowering treatment. Women without CVD were less likely than men to have LDL cholesterol controlled with no differences in SBP or A1C control. Women with diabetes and CVD have poorer control of important modifiable risk factors than men and receive less intensified lipid-lowering treatment.
Medical subject headings
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
- Diabetic Angiopathies
- Sex Characteristics